The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Nanosizing — Oral formulation development and biopharmaceutical evaluation
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Foundations of Colloid Science
Hunter, R. J. (1987) · Cited by 3,747
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
THE RATE OF SOLUTION OF SOLID SUBSTANCES IN THEIR OWN SOLUTIONS.
Noyes, A. A., & Whitney, W. R. (1897) · Journal of the American Chemical Society · doi:10.1021/ja02086a003 · Cited by 1,884
Foundations of Colloid Science
Blees, M. H. (2002) · Colloids and Surfaces A: Physicochemical and Engineering Aspects · doi:10.1016/s0927-7757(02)00170-x · Cited by 1,760
Freeze-drying of nanoparticles: Formulation, process and storage considerations
ABDELWAHED, W., DEGOBERT, G., STAINMESSE, S., & FESSI, H. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.017 · Cited by 1,611
Nanosuspensions in drug delivery
Rabinow, B. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1494 · Cited by 1,524
Allen, T. (1981) · Springer eBooks · doi:10.1007/978-1-4899-3063-7 · Cited by 1,472
Nanosuspensions as particulate drug formulations in therapy
Müller, R. H., Jacobs, C., & Kayser, O. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00118-6 · Cited by 1,370
Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs
Neslihan Gursoy, R., & Benita, S. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.02.001 · Cited by 1,358
Nanosizing: a formulation approach for poorly-water-soluble compounds
Merisko-Liversidge, E., Liversidge, G. G., & Cooper, E. R. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00251-8 · Cited by 1,263
Pouton, C. W. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00167-6 · Cited by 1,230
Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation
KECK, C., & MULLER, R. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.05.009 · Cited by 1,061
Nanosuspensions: a promising drug delivery strategy
Patravale, V. B., Date, A. A., & Kulkarni, R. M. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357023691 · Cited by 904
Theorie der Reaktionsgeschwindigkeit in heterogenen Systemen
Nernst, W. (1904) · Zeitschrift für Physikalische Chemie · doi:10.1515/zpch-1904-4704 · Cited by 899
Jinno, J.-I., Kamada, N., Miyake, M., Yamada, K., Mukai, T., Odomi, M., Toguchi, H., Liversidge, G. G., Higaki, K., & Kimura, T. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.11.013 · Cited by 510
Nanosuspensions for the Formulation of Poorly Soluble Drugs
Müller, R., Jacobs, C., & Kayser, O. (2000) · Drugs and the Pharmaceutical Sciences · doi:10.1201/b14005-13 · Cited by 501
Nanosuspensions for the formulation of poorly soluble drugs
Müller, R. H., & Peters, K. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00311-6 · Cited by 480
Mosharraf, M., & Nyström, C. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)00033-f · Cited by 386
Reaktionsgeschwindigkeit in heterogenen Systemen
Brunner, E. (1904) · Zeitschrift für Physikalische Chemie · doi:10.1515/zpch-1904-4705 · Cited by 382
Yu, L. X., Lipka, E., Crison, J. R., & Amidon, G. L. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(96)00009-9 · Cited by 335
Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN®) versus drug nanocrystals
Müller, R. H., Runge, S., Ravelli, V., Mehnert, W., Thünemann, A. F., & Souto, E. B. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.045 · Cited by 304
Wu, Y., Loper, A., Landis, E., Hettrick, L., Novak, L., Lynn, K., Chen, C., Thompson, K., Higgins, R., Batra, U., et al. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.08.001 · Cited by 275
Self-citationPeters, K. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.1.77 · Cited by 228
Lui, C. Y., Amidon, G. L., Berardi, R. R., Fleisher, D., Youngberg, C., & Dressman, J. B. (1986) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600750313 · Cited by 201
Formulation of amphotericin B as nanosuspension for oral administration
Kayser, O. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00686-5 · Cited by 186
Current strategies for engineering drug nanoparticles
Date, A. A., & Patravale, V. B. (2004) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2004.06.009 · Cited by 171
Nanomilling in stirred media mills
Stenger, F., Mende, S., Schwedes, J., & Peukert, W. (2005) · Chemical Engineering Science · doi:10.1016/j.ces.2005.02.057 · Cited by 165
Schöler, N., Krause, K., Kayser, O., Müller, R. H., Borner, K., Hahn, H. H., & Liesenfeld, O. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1771-1779.2001 · Cited by 140
Hu, J., Johnston, K. P., & Williams, R. O. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00203-3 · Cited by 127
Pharmacokinetics of Aprepitant After Single and Multiple Oral Doses in Healthy Volunteers
Majumdar, A. K., Howard, L. M., Goldberg, M. R., Hickey, L., Constanzer, M. L., Rothenberg, P., Crumley, T. M., Panebianco, D. L., Bradstreet, T. E., Bergman, A. J., et al. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005283467 · Cited by 101
Langguth, P., Hanafy, A., Frenzel, D., Grenier, P., Nhamias, A., Ohlig, T., Vergnault, G., & Spahn-Langguth, H. (2005) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-52182 · Cited by 98
Single dose and multiple dose studies of itraconazole nanoparticles
Vaughn, J. M., McConville, J. T., Burgess, D., Peters, J. I., Johnston, K. P., Talbert, R. L., & Williams, R. O. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.01.006 · Cited by 85
Jia, L., Wong, H., Wang, Y., Garza, M., & Weitman, S. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10272 · Cited by 80
Mouton, J. W., Peer, A. V., Beule, K. D., van Vliet, A., Donnelly, J. P., & Soons, P. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00630-06 · Cited by 75
Vaughn, J. M., McConville, J. T., Crisp, M. T., et al. (2006) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040500529176 · Cited by 53
Cited by
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Kawabata, Y., Wada, K., Nakatani, M., Yamada, S., & Onoue, S. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.032 · Cited by 1,181
Physical and chemical stability of drug nanoparticles
Wu, L., Zhang, J., & Watanabe, W. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.02.001 · Cited by 993
Advances in Oral Drug Delivery
Alqahtani, M. S., Kazi, M., Alsenaidy, M. A., & Ahmad, M. Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.618411 · Cited by 876
Curcumin Nanoparticles: Preparation, Characterization, and Antimicrobial Study
Bhawana, Basniwal, R. K., Buttar, H. S., Jain, V. K., & Jain, N. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf104402t · Cited by 863
Metadata
- Authors
- Kesisoglou, F., Panmai, S., & Wu, Y.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2007-07
- Volume
- 59
- Issue
- 7
- Pages
- 631-644
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2001596955
- Cited by
- 1,055
- References
- 35
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.